IntriCon

IntriCon Corporation, through its subsidiaries, engages in the design, development, engineering, and manufacture of body-worn devices and electronic products. Subsidiaries The company's subsidiaries include IntriCon, Inc., IntriCon PTE LTD (PTE), and IntriCon Tibbetts, Inc. (ITC). Segments The company operates through two segments: Body Worn Device segment and Electronics Products segment. BODY-WORN DEVICES   The company markets its products in the United States, Germany, China, Switzerland, Singapore, Japan, France, the United Kingdom, Turkey, and Hong Kong.   IntriCon Corporation was founded in 1930.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Investment by Altaris Supports Intricon's Ability to Deliver Innovative Solutions and Service to its Customers Investment by Altaris Supports Intricon's Ability to Deliver Innovative Solutions and Service to its Customers

Intricon Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners

Origin Bancorp Inc

Vectrus

Alleghany

NEW YORK , April 26, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Origin Bancorp, Inc. (NASDAQ: OBNK)'s merger with BT Holdings, Inc. (BTH). Under the terms of the agreement, BTH shareholders will receive an aggregate of 6,828,390 shares of Origin's common stock in exchange for all outstanding shares of BTH common stock, subject to certain adjustments.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates OBNK, IIN, Y, VEC

TDK Corp

TTDKY vs. IIN: Which Stock Is the Better Value Option?

TTDKY vs. IIN: Which Stock Should Value Investors Buy Now?

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intricon Corporation (NasdaqGM: IIN) to an affiliate of Altaris Capital Partners, LLC. Under the terms of the proposed transaction, shareholders of Intricon will receive only $24.25 in cash for each share of Intricon that they own. KSF is seeking to determine whether this consideration and the process that led

INTRICON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intricon Corporation - IIN

Eli Lilly

Moderna

Novavax

Teladoc

Do these healthcare stocks pique your interest?

Stocks To Invest In Right Now? 5 Health Care Stocks For Your March Watchlist

The IntriCon Corporation (NASDAQ: IIN) stock increased by 37.37% today. This is why.

IntriCon Corporation (IIN) Stock: Why It Surged Today

NEW YORK , Feb. 28, 2022 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IntriCon Corporation ("IntriCon" or the "Company") (NASDAQ: IIN), in connection with the proposed acquisition of the Company by an affiliate of Altaris Capital Partners, LLC ("Altaris").  Under the terms of the merger agreement, the Company's shareholders will receive $24.25 in cash for each share of IntriCon common stock that they hold.

SHAREHOLDER ALERT: WeissLaw LLP Investigates IntriCon Corporation

Wilmington, Delaware--(Newsfile Corp. - February 28, 2022) - Rigrodsky Law, P.A. announces that it is investigating Intricon Corporation ("Intricon") (NASDAQ: IIN) regarding possible breaches of fiduciary duties and other violations of law related to Intricon's agreement to be acquired by an affiliate of Altaris Capital Partners. Under the terms of the agreement, Intricon's shareholders will receive $24.25 in cash for each share of Intricon common stock they own.To learn more about this investigation and your...

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Intricon Corporation Buyout

Altaris Capital Partners LLC will acquire Implantable device maker Intricon Corporation (NASDAQ: IIN) for $24.25 per share in a transaction that values Intricon at an equity value of approximately $241 million.  The purchase price represents a premium of approximately 39%.

Why Are Intricon Shares Surging Monday

MILWAUKEE, Feb. 28, 2022 /PRNewswire/ -- Ademi LLP is investigating Intricon (NASDAQ: IIN) for possible breaches of fiduciary duty and other violations of law in its transaction with Altaris.  Click here to learn how to join the action: https://www.ademilaw.com/case/intricon-corporation or call Guri Ademi toll-free at 866-264-3995.

Shareholder Alert: Ademi LLP investigates whether Intricon Corporation has obtained a Fair Price in its transaction with Altaris.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of IntriCon Corporation (NASDAQ: IIN) to an affiliate of Altaris Capital Partners, LLC for $24.25 per share is fair to IntriCon shareholders. Halper Sadeh encourages IntriCon shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concern

IIN Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of IntriCon Corporation Is Fair to Shareholders

IntriCon Corporation (IIN) delivered earnings and revenue surprises of 2,200% and 6.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

IntriCon Corporation (IIN) Q4 Earnings and Revenues Surpass Estimates

ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its fourth quarter and year ended December 31, 2021.

Intricon Reports Fourth Quarter and Full Year 2021 Results

Intricon Shareholders to Receive $24.25 Per Share in Cash Intricon Shareholders to Receive $24.25 Per Share in Cash

Intricon Enters into Agreement to be Acquired by an Affiliate of Altaris Capital Partners for $241 Million

IntriCon Corporation (IIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: IntriCon Corporation (IIN) Q4 Earnings Expected to Decline

IntriCon Corporation (IIN) CEO Scott Longval on Q3 2021 Results - Earnings Call Transcript

IntriCon Corporation (IIN) delivered earnings and revenue surprises of 466.67% and -0.16%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

IntriCon Corporation (IIN) Beats Q3 Earnings Estimates

IntriCon (NASDAQ:IIN) reported its Q3 earnings results on Monday, November 8, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

Recap: IntriCon Q3 Earnings

ARDEN HILLS, Minn., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its third quarter ended September 30, 2021.

Intricon Reports Third Quarter 2021 Results

IntriCon (IIN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why IntriCon (IIN) Might Surprise This Earnings Season

Earnings Preview: IntriCon Corporation (IIN) Q3 Earnings Expected to Decline

ARDEN HILLS, Minn., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, announced today that Ellen Scipta has stepped down from her position as Chief Financial Officer, effective October 29, 2021. Annalee Lutgen, current Treasurer and Director of Finance, will serve as interim Chief Financial Officer effective upon Ms. Scipta's resignation as the company conducts its search for a permanent replacement.

Intricon Announces CFO Departure and Preliminary Third Quarter 2021 Revenue

Kyocera Corp

KYOCY vs. IIN: Which Stock Is the Better Value Option?

KYOCY or IIN: Which Is the Better Value Stock Right Now?

ARDEN HILLS, Minn., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2021 third quarter results on Monday, November 8, 2021, after market close.

News for IntriCon Stock (IIN)